Harnessing Molecular Imaging to Capture Cancer (Communities - News & Events)

Item ID 3167364 in Category: Communities - News & Events

Harnessing Molecular Imaging to Capture Cancer
Positron Emission Tomography (PET) offers a groundbreaking approach to cancer care, enabling the visualization of molecular processes within the body, revolutionizing diagnostics and treatment monitoring. Dr. Gabriela Kramer-Marek, leading the Preclinical Molecular Imaging Team at The Institute of Cancer Research, London, delves into the potential of molecular imaging to predict individual treatment responses. Her team focuses on human epidermal growth factor receptors (EGFR), particularly HER3, implicated in various cancers’ progression and resistance to targeted therapies like trastuzumab and cetuximab. Traditionally, assessing receptor status involves invasive tissue sampling, prone to errors and delays. Dr. Kramer-Marek aims to develop non-invasive imaging biomarkers for accurate receptor assessment, enabling real-time monitoring of treatment responses. This approach promises personalized treatment adjustments and reduces false results. For more details please visit our website - https://www.medhealthinsight.com/new-soundboard-review-pricing-is-not-always-the-only-criteria-2-11-2-64/
Related Link: Click here to visit item owner's website (0 hit)

Target State: New York Target City : New work city Last Update : Nov 17, 2025 6:10 AM Number of Views: 6	Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None)

Friendly reminder: Click here to read some tips.

2025-11-17 (0.403 sec)